Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Does Hedge Fund Sentiment Say about General Motors Company (GM)?

Page 1 of 2

General Motors Company (NYSE:GM) does not need too much of an introduction, indeed. The largest US-based automaker has been seriously hit by China’s deepening economic slowdown, and in August saw its biggest fall in sales in the region over the last five months. Even so, the stock is very popular among the hedge funds tracked by Insider Monkey. There were 104 investors within our database that held stakes in General Motors at the end of the second quarter, compared with 103 registered in the prior quarter. At the same time, the overall value of their stakes amounted to $5.78 billion, representing almost 11% of the outstanding stock, down from $6.74 billion quarter-over-quarter. In the following article, we will discuss GM’s recent performance and investors’ expectations regarding the company.

General Motors Company (NYSE:GM), Sign, logo, Building, Symbol, Headquarters, Car

Linda Parton /

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read more details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 118% and beating the market by more than 60 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

Let’s now discuss on what reputable hedge fund managers think of General Motors Company (NYSE:GM). David Einhorn of Greenlight Capital, the third-largest shareholder of the automaker within our database, mentioned GM in a letter to investors for the first quarter of 2015. According to the letter, Greenlight Capital “decided to take another drive in General Motors” in the first quarter and acquired a new stake at $34.62 per share. The investment firm had owned shares of GM for nearly three years prior to selling its stake in early 2014, when the company’s earnings guidance “disappointed” David Einhorn’s team.

“2015 should be a better year for GM: the company is a year closer to eliminating its losses in Europe; low gas prices should stimulate demand for its highly profitable SUV and light truck product lines; raw material costs are low; and we believe that the worst of the product recalls is behind them. Finally, GM has acknowledged it might not need quite so much cash lying around earning zero interest, and it will begin to buy back shares shortly. While GM also trades at less than 8x 2015 consensus estimates of $4.63 per share, we believe there is an excellent chance that GM can beat those expectations,” Einhorn added.

General Motors’ stock closed the second quarter at $37.50, but they have lost over 20% since then. David Einhorn could have not anticipated China’s disastrous economic pullback, which indubitably has had a significant impact on the company’s stock performance and its top-line in particular. Let’s not forget to mention that David Einhorn’s Greenlight Capital reported owning 14.65 million shares at the end of the second quarter, representing 6.12% of its entire portfolio. Meanwhile, the value of the stake added up to $488.14 million on June 30.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!